No Data
No Data
The Analyst Landscape: 13 Takes On Edwards Lifesciences
13 analysts have expressed a variety of opinions on Edwards Lifesciences (NYSE:EW) over the past quarter, offering a diverse set of opinions from bullish to bearish.The following table encapsulates th
Deutsche Bank's Fresh Money List for 3Q
Edwards Lifesciences Is Maintained at In-Line by Evercore ISI Group
Edwards Lifesciences Is Maintained at In-Line by Evercore ISI Group
Edwards Lifesciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/02/2024 1.51% Evercore ISI Group $89 → $91 Maintains In-Line 05/30/2024 19.35% Goldman Sachs → $107 Ini
Evercore Maintains Edwards Lifesciences(EW.US) With Hold Rating, Raises Target Price to $91
Evercore analyst Vijay Kumar maintains $Edwards Lifesciences(EW.US)$ with a hold rating, and adjusts the target price from $89 to $91.According to TipRanks data, the analyst has a success rate of 47.4
Evercore ISI Adjusts Price Target on Edwards Lifesciences to $91 From $89, Maintains In-line Rating
Edwards Lifesciences (EW) has an average outperform rating and a price target range of $70 to $107, according to analysts polled by Capital IQ. Price: 91.00, Change: +0.75, Percent Change: +0.83
No Data